401 related articles for article (PubMed ID: 10788334)
1. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
Górski B; Byrski T; Huzarski T; Jakubowska A; Menkiszak J; Gronwald J; Pluzańska A; Bebenek M; Fischer-Maliszewska L; Grzybowska E; Narod SA; Lubiński J
Am J Hum Genet; 2000 Jun; 66(6):1963-8. PubMed ID: 10788334
[TBL] [Abstract][Full Text] [Related]
2. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
Byrski T
Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838
[TBL] [Abstract][Full Text] [Related]
3. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
[TBL] [Abstract][Full Text] [Related]
4. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
[TBL] [Abstract][Full Text] [Related]
5. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
Levy-Lahad E; Catane R; Eisenberg S; Kaufman B; Hornreich G; Lishinsky E; Shohat M; Weber BL; Beller U; Lahad A; Halle D
Am J Hum Genet; 1997 May; 60(5):1059-67. PubMed ID: 9150153
[TBL] [Abstract][Full Text] [Related]
6. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.
Ikeda N; Miyoshi Y; Yoneda K; Shiba E; Sekihara Y; Kinoshita M; Noguchi S
Int J Cancer; 2001 Jan; 91(1):83-8. PubMed ID: 11149425
[TBL] [Abstract][Full Text] [Related]
7. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.
Górski B
Hered Cancer Clin Pract; 2006 Aug; 4(3):142-52. PubMed ID: 20223018
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy.
Santarosa M; Dolcetti R; Magri MD; Crivellari D; Tibiletti MG; Gallo A; Tumolo S; Della Puppa L; Furlan D; Boiocchi M; Viel A
Int J Cancer; 1999 Sep; 83(1):5-9. PubMed ID: 10449599
[TBL] [Abstract][Full Text] [Related]
9. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
Grzybowska E; Zientek H; Jasinska A; Rusin M; Kozlowski P; Sobczak K; Sikorska A; Kwiatkowska E; Gorniak L; Kalinowska E; Utracka-Hutka B; Wloch J; Chmielik E; Krzyzosiak WJ
Hum Mutat; 2000 Dec; 16(6):482-90. PubMed ID: 11102977
[TBL] [Abstract][Full Text] [Related]
10. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
[TBL] [Abstract][Full Text] [Related]
11. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
[TBL] [Abstract][Full Text] [Related]
12. A high proportion of founder BRCA1 mutations in Polish breast cancer families.
Górski B; Jakubowska A; Huzarski T; Byrski T; Gronwald J; Grzybowska E; Mackiewicz A; Stawicka M; Bebenek M; Sorokin D; Fiszer-Maliszewska Ł; Haus O; Janiszewska H; Niepsuj S; Góźdź S; Zaremba L; Posmyk M; Płuzańska M; Kilar E; Czudowska D; Waśko B; Miturski R; Kowalczyk JR; Urbański K; Szwiec M; Koc J; Debniak B; Rozmiarek A; Debniak T; Cybulski C; Kowalska E; Tołoczko-Grabarek A; Zajaczek S; Menkiszak J; Medrek K; Masojć B; Mierzejewski M; Narod SA; Lubiński J
Int J Cancer; 2004 Jul; 110(5):683-6. PubMed ID: 15146557
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.
Moslehi R; Chu W; Karlan B; Fishman D; Risch H; Fields A; Smotkin D; Ben-David Y; Rosenblatt J; Russo D; Schwartz P; Tung N; Warner E; Rosen B; Friedman J; Brunet JS; Narod SA
Am J Hum Genet; 2000 Apr; 66(4):1259-72. PubMed ID: 10739756
[TBL] [Abstract][Full Text] [Related]
14. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.
Håkansson S; Johannsson O; Johansson U; Sellberg G; Loman N; Gerdes AM; Holmberg E; Dahl N; Pandis N; Kristoffersson U; Olsson H; Borg A
Am J Hum Genet; 1997 May; 60(5):1068-78. PubMed ID: 9150154
[TBL] [Abstract][Full Text] [Related]
15. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.
Unger MA; Nathanson KL; Calzone K; Antin-Ozerkis D; Shih HA; Martin AM; Lenoir GM; Mazoyer S; Weber BL
Am J Hum Genet; 2000 Oct; 67(4):841-50. PubMed ID: 10978226
[TBL] [Abstract][Full Text] [Related]
16. Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed.
Ladopoulou A; Kroupis C; Konstantopoulou I; Ioannidou-Mouzaka L; Schofield AC; Pantazidis A; Armaou S; Tsiagas I; Lianidou E; Efstathiou E; Tsionou C; Panopoulos C; Mihalatos M; Nasioulas G; Skarlos D; Haites NE; Fountzilas G; Pandis N; Yannoukakos D
Cancer Lett; 2002 Nov; 185(1):61-70. PubMed ID: 12142080
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population.
Grzybowska E; Siemińska M; Zientek H; Kalinowska E; Michalska J; Utracka-Hutka B; Rogozińska-Szczepka J; Kaźmierczak-Maciejewska M
Acta Biochim Pol; 2002; 49(2):351-6. PubMed ID: 12362976
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer.
Hodgson SV; Heap E; Cameron J; Ellis D; Mathew CG; Eeles RA; Solomon E; Lewis CM
J Med Genet; 1999 May; 36(5):369-73. PubMed ID: 10353781
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.
Rashid MU; Zaidi A; Torres D; Sultan F; Benner A; Naqvi B; Shakoori AR; Seidel-Renkert A; Farooq H; Narod S; Amin A; Hamann U
Int J Cancer; 2006 Dec; 119(12):2832-9. PubMed ID: 16998791
[TBL] [Abstract][Full Text] [Related]
20. Genetic testing in Poland and Ukraine: should comprehensive germline testing of
Nguyen-Dumont T; Karpinski P; Sasiadek MM; Akopyan H; Steen JA; Theys D; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Stembalska A; Pesz K; Kitsera N; Siekierzynska A; Southey MC; Myszka A
Genet Res (Camb); 2020 Aug; 102():e6. PubMed ID: 32772980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]